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tool and disseminated it to a self-selected cohort of 11 small primary care practices 
that had previously achieved PCMH recognition from the NCQA. We assessed the 
cost of transformation between 2008 and 2011 using the tool. The cost of transfor-
mation was divided into four categories: the cost of NCQA patient centered recog-
nition activities, the application cost of obtaining recognition, the cost of changes 
to practice culture, and the cost of external collaborations. Costs were averaged 
and weighted by the number of FTE providers in each practice in order to make 
the results comparable across practices. RESULTS: Three practices completed the 
tool. The weighted average cost of PCMH transformation was $35,508 per FTE pro-
vider in the year before recognition was achieved, and $38,218 in the recognition 
year itself. The most costly patient-centered activity (weighted average) in the pre-
transformation year was “providing self-care support” ($4,863/FTE provider), while 
“measuring and improving performance” ($9,503/FTE provider) was the most costly 
in the transformation year. CONCLUSIONS: The cost of recognition as a PCMH is a 
substantial but not insurmountable barrier to practice transformation. This informa-
tion may be used by payers and policymakers to direct financial resources to primary 
care practices as they transform to the PCMH model. Indirect financial resources 
that assist in collecting cost data may also promote diffusion of the PCMH model.
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OBJECTIVES: Patient-centered outcomes have become increasingly important 
and relevant in making informed healthcare decisions. However, the influence of 
patient’s perspective in economic evaluation studies remains unknown. This study 
sought to systematically review CEA studies conducted from the patient’s perspec-
tive. METHODS: PUBMED, EMBASE, and Cochrane Central database were searched 
through May 2014 for CEA studies that used patient’s perspective. Essential char-
acteristics of these economic studies were extracted and compared. The reporting 
quality of these studies was evaluated using the ISPOR guideline, Consolidated Health 
Economic Evaluation Reporting Standards (CHEERS). RESULTS: A total of 21 out of 
32 studies retrieved met the inclusion criteria. These studies, in average, met 17 of 24 
reporting criteria specified in CHEERS, and were conducted in the US (5), Europe (6), 
Asia (6), and others (4). Among the 21 CEA studies, 9 evaluated pharmacotherapy and 
12 non-drug intervention. Of the 8 studies that mentioned reasons for using patient’s 
perspective, patient’s consideration of financial burden associated with medical inter-
vention was the most common one (7), followed by possible influence on patient 
adherence and utilization of resources (1). Societal (3), government (1), institutional 
(12), or third-party payer (2) perspectives were also used in majority of the studies. 
Direct medical cost generally considered in the studies were out-of-pocket costs such 
as copayment or co-insurance for drugs, office visits, tests, and procedures, whereas 
direct non-medical cost included travel and food cost. Sensitivity analyses were per-
formed in 19 studies, and governmental agencies or university grants were the most 
common funding sources (14) disclosed by17 studies. CONCLUSIONS: Currently, there 
is a paucity of CEA studies conducted from patient’s perspective in the literature, and 
the reporting quality of these studies was not optimal. With the increasing focus of 
patient-centered outcomes in health policy research, use of patient’s perspective in 
economic studies should be advocated.
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OBJECTIVES: In observational studies, identification of the impact of increased cost 
sharing on expenditures is plagued by an individual’s self-selection into copay-
ment and deductible levels based on their health state. The objective of this study 
was to evaluate the effect of increasing patient’s cost sharing on future third party 
expenditures using an instrumental variables (IV) approach to mitigate selection 
bias. METHODS: Data from the Medical Expenditure Panel Survey’s Longitudinal 
Household Component (2011-2012), a nationally representative survey of the U.S. 
civilian non-institutionalized population, was used. Analysis accounted for the 
survey’s clusters, strata, and sampling weights. Respondents were included in the 
study if they were at or above the age of 18 and if they had insurance coverage. We 
evaluated the effect of patient’s out-of-pocket payments on total third party expen-
ditures in the following year, using a limited information maximum likelihood IV 
estimator. The three excluded instruments determining self-selected levels of cost 
sharing were, attitudes toward health insurance; attitudes that might influence 
decisions to use health services; and perceived physical health status. We evalu-
ated the validity of our IV estimation assumptions on instrument relevance and 
exogeneity using several tests. Other covariates adjusted in the models included age, 
sex, race, ethnicity, family size, income, geographic-location, and comorbidities in 
2011. RESULTS: The mean age of the sample was 46 with a majority of female (52%); 
Caucasian (81%); and non-Hispanic (85%). The endogeneity test rejected the null 
hypothesis that there was no self-selection. The IV estimates indicated that an one 
dollar increase in patient’s cost sharing increased future third party expenditures 
by $12.6 (95% CI = 5.7 to 19.4). In contrast, naïve estimates ignoring endogeneity 
displayed a modest increase of $0.6 (95% CI = 0.2 to 1.0). CONCLUSIONS: Health 
policy effect of increasing patient’s cost sharing to reduce health expenditures may 
have an opposite effect and increase future expenditures.
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breast cancer in 2008, for HCV treatments in April 2014, and, for an appraisal of 
new HCV treatments in December 2014. CONCLUSIONS: CTAF have appraised a 
wide range of technologies but have only started appraising pharmaceuticals very 
recently. Gaining CTAF approval is far from a formality with over half of appraisals 
being not recommended. As management of rising healthcare costs continues to 
become an increasing payer challenge, CTAF will likely appraise greater numbers of 
high-cost pharmaceuticals using cost-utility analyses with their recommendations 
potentially becoming increasingly influential.
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OBJECTIVES: To characterize differences between Hispanic and non-His-
panic white adults in the United States with regard to healthcare resource 
utilization and costly health conditions. METHODS: Demographics and 
healthcare resource utilization among Hispanic and non-Hispanic white 
adults (≥ 20 years) were compared from a cross-sectional study using de-iden-
tified data from the 2013 National Health Interview Survey. The most costly 
health conditions for each population were identified from the 2010-2011 
Medical Expenditure Panel Survey (MEPS). RESULTS: While sex distribution 
was similar in both cohorts, the Hispanic cohort was generally younger (P< 0.0001; 
50.1% in the 20-39 year range vs 31.3% of non-Hispanic whites), with lower educa-
tion (P< 0.0001) and household income (P< 0.0001), although employment was higher 
(63.5% vs 57.5%; P< 0.0001). Relative to non-Hispanic whites, greater proportions of 
Hispanics reported not having a physician visit in the past year (30.9% vs 16.5%; 
P< 0.0001) and less emergency room use (17.3% vs 18.3%; P= 0.0094). Utilization of 
several preventative resources was significantly lower among Hispanics, including 
flu vaccination (31.9% vs 43.8%; P< 0.0001), pneumonia vaccination (14.0% vs 22.4%; 
P< 0.0001), mammograms among females ≥ 40 years (53.2% vs 56.8%; P= 0.0418), 
and prostate-specific antigen tests among males ≥ 40 years (29.6% vs 44.5%; 
P< 0.0001); however, PAP tests were similar among females (Hispanic 48.4%, white 
50.4%; P= 0.1897), as was colonoscopy among those ≥ 50 years (23% in both groups; 
P= 0.9137). MEPS data showed differences in the most costly conditions. In subjects 
aged ≥ 65 years, the most costly conditions were heart disease in Hispanics and 
diabetes mellitus among non-Hispanic whites. For those < 65 years, the most costly 
conditions in males were trauma-related disorders among Hispanics and heart 
conditions in non-Hispanic whites; births was the most costly condition among 
females in both cohorts. CONCLUSIONS: Hispanics were characterized by lower fre-
quency of physician visits and several preventative/screening healthcare measures, 
suggesting different healthcare cost drivers compared with non-Hispanic whites.
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OBJECTIVES: Since 2011, the Centers for Medicare and Medicaid Services has 
required all long term care facilities to implement a short fill supply for all solid 
oral dosage forms in order to reduce medication wastage from medication discon-
tinuation. The objective of this study was to evaluate potential savings that could be 
achieved from a 15-day initial fill policy for selected out-patient medications in the 
Mississippi Medicaid program. METHODS: A retrospective analysis was conducted 
using Mississippi Medicaid fee-for-service and managed care pharmacy claims data 
for the period January 1, 2013 through December 31, 2013. Oral drugs, costing more 
than $1000 per prescription, were evaluated for inclusion in the 15-day initial fill 
model. All new starts for these medications during the year were identified and ana-
lyzed for persistency and average amount paid. Medications were selected for fur-
ther evaluation based on (a) 50+% of new starts stayed on therapy for 90+ days and 
(b) 5+% of new starts had discontinued therapy before 30 days. Drugs which were 
expected to generate the most savings from this policy were then identified for the 
final list for evaluating potential savings from a 15-day initial fill policy. RESULTS: 
A total of 19 unique drugs were included in the final analysis of potential savings 
from a 15-day initial fill policy. These drugs were associated with high costs per 
prescription and high discontinuation rates. Assuming savings of 15-days of therapy 
from all discontinuations, the total annual savings from these 19 drugs was esti-
mated to be $23.3 million. A conservative estimate with savings from only 50% of 
discontinuations was an annual savings of $11.6 million. CONCLUSIONS: Results 
indicate substantial savings could be achieved from a 15-day initial fill policy for 
some outpatient medications. Further consideration of such a policy must take into 
account the specific disease state and potential problems in disruption of therapy.
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OBJECTIVES: While there is ample information on the activities needed to trans-
form into a patient-centered medical home (PCMH), previous research lacks focus 
on cost as an obstacle to transformation. This is particularly important in small 
primary care practices (< 10 full-time equivalent [FTE] providers), which serve a 
large number of outpatients. Therefore, the objective of this study was to estimate 
the cost of achieving and sustaining PCMH recognition for small primary care prac-
tices. METHODS: Using semi-structured interviews, we developed a cost collection 
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OBJECTIVES: Health care costs in Massachusetts (MA) are among the highest in 
the country. Thus, it is essential to gain an in-depth understanding of the pat-
terns of healthcare resource utilization and expenditures in the state. This study 
examines healthcare spending in the state by care setting, and compares where 
most spending occurs for Medicaid and private payers. METHODS: We used the 
2012 MA All Payer Claims Database, which included medical and pharmacy claims 
from all commercial payers and certain public programs (Medicare Part C only 
and Medicaid) to calculate healthcare utilization and expenditures for the state’s 
population (N= 6,549,289 individuals), including patient out-of-pocket payments. 
Traditional Medicare claims were not included in this analysis. We conducted 
descriptive analyses to calculate and compare total annual healthcare spending by 
site of service for Medicaid and private payers. RESULTS: Total healthcare spend-
ing for MA in 2012 amounted to $25 billion for private payers and $10.3 billion 
for the state Medicaid program. For private payers, pharmacy claims accounted 
for 27% of total healthcare spending, and the top sites of service by spending 
were hospital outpatient (26%), hospital inpatient (19%), and office visits (15%). 
For Medicaid, the biggest contributors to healthcare spending were office visits 
(22%), followed by hospital inpatient visits (17%), skilled nursing facility visits (16% 
versus only 0.3% for private), and home health visits (14% versus 1.5% in private), 
with pharmacy claims comprising 12% of spending. CONCLUSIONS: We identi-
fied differences in patterns of healthcare resource utilization and expenditures 
between Medicaid and private payers. These differences reflect demographic and 
pattern of care differences in the insured populations, as well as different payment 
policies and prices paid for services. In order to improve care quality, equity, and 
efficiency, it is important to understand how money is being spent by different 
segments of the healthcare market.
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OBJECTIVES: The adaption of technological advances in the past decades under-
scores the importance of measuring how efficiently hospitals are utilizing the 
growing labor force to provide health services. Our study aimed to assess California 
hospital productivity growth through addressing the severity of patient’s illness 
and outcomes of care. METHODS: We examined hospital productivity growth 
by analyzing patient discharge data from California for the period 2005 to 2011, 
among patient stays with a principal diagnosis of heart attack, pneumonia or 
heart failure. Productivity was defined by the ratio of the number of stays to 
total costs in each hospital-year. RESULTS: The study cohorts included 171,250 
patient stays at 358 hospitals with a primary diagnosis of heart attack, 336,111 
stays at 387 hospitals with pneumonia, and 389,413 stays at 383 hospitals with 
heart attack. Average costs per stay showed a slightly increasing trend from 2005 
to 2011 (from $22,965 to $23,669 in heart-attack stays, from $10,956 to $12,238 in 
pneumonia stays, and from $13,279 to $14,144 in heart-failure stays, all in 2011 
dollars). The average number of patient comorbidities increased by 37% for heart 
attack, 28% for pneumonia, and 87% for heart failure. A decreasing trend was 
observed in inpatient mortality rate, ranging from 26% for heart attack to 19% 
for pneumonia. Unadjusted annual productivity growth rates were significantly 
negative (-0.7% per year for heart-attack stays, -2.4% for pneumonia stays, and 
-1.5% for heart-failure stays). In contrast, after adjustment for patient severity of 
illness and inpatient survival, annual productivity growth rates became +0.4% per 
year for heart attack and +0.2% for heart failure; growth for pneumonia was no 
longer significantly negative. CONCLUSIONS: Accounting for patient severity and 
quality of care, as is appropriate, results in substantially more favorable trends in 
productivity growth at California hospitals.
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OBJECTIVES: As have many states, Mississippi Medicaid has witnessed a major 
shift from fee-for-service to managed care with in the last few years. In November 
2012, managed care enrollment was increased to almost 30% with the aim of 
improving health care service quality and reducing costs. However, the effects of 
this shift of patients to managed care has not been thoroughly evaluated. This 
project aimed to evaluate the impact of the shift of patients from fee-for-ser-
vice to managed care on health care utilization, quality and costs. METHODS: 
A retrospective analysis was conducted using Mississippi Medicaid FFS admin-
istrative claims and beneficiary eligibility data for the period November 1, 2011 
through December 31, 2013. A cohort of beneficiaries were identified who were 
continuously enrolled for this period and spent the first 12 months enrolled in 
fee-for-service and the next 12 months in managed care. Various outcomes were 
measured for the first 12-month and the second 12-month periods. An additional 
cohort of beneficiaries who were enrolled in fee-for-service for the whole dura-
tion of the study period were also followed on the same measures as a control 
group. RESULTS: The number of medications filled, number of office visits, inten-
sity of office visits, total pharmacy costs and total outpatients costs were found 
to increase after the shift to managed care. Days of inpatient stay, inpatient costs 
and ER costs all decreased. It appears that the shift to managed care has caused 
an increase in outpatient and pharmacy utilization and costs and a decrease in 
inpatient costs. CONCLUSIONS: The shift to managed care seems to have a mixed 
effect on health care use and spending for Mississippi Medicaid beneficiaries. 
Increased use of outpatient services while inpatient costs decrease may indicate 
a more appropriate level of care being used. Further analysis is needed to provide 
conclusive results.
OBJECTIVES: Waste in prescribing, dispensing, and consumption of medications in 
community settings significantly impacts the US Health Care System. This research 
examines waste associated with the medication use process which consists of any 
written prescriptions that are not (1) taken to a pharmacy to be filled, (2) taken 
to be filled but abandoned at the pharmacy, or (3) result in a medication being 
dispensed but not consumed as directed. The aim of this study is to quantify the 
costs of medication waste in the United States exclusive of impact on health out-
comes. METHODS: A review of published literature and data from the 2012 Medical 
Expenditure Panel Survey was used to quantify the number of prescriptions wasted 
at different stages of the medication prescribing and use process. Costs associated 
with medication waste included physician time and overhead lost writing prescrip-
tions, pharmacist time and overhead lost filling prescriptions, and ingredient costs 
of medications not used. RESULTS: In 2012, more than 8 million prescriptions were 
either unfilled or abandoned, and 70 million resulted in dispensed medications 
that were not used. The total cost of this waste was estimated at more than $14 
billion. This result excluded any additional costs associated with not achieving 
desired health outcomes. CONCLUSIONS: Patients who do not fulfill their role in 
the medication use process cause significant, avoidable costs to the health care 
system beyond the health outcomes not achieved.
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OBJECTIVES: Patients undergoing major surgeries often experience post-surgical 
complications. The impact of post-surgical complications on hospital costs has been 
extensively studied but the impact on margins remains a subject of controversy. We 
assessed the financial consequences of postsurgical complications in high-risk US 
Medicare patients undergoing specific procedures. METHODS: Data from Medicare 
patients with ≥1 comorbidity who had major cardiac, vascular, gastro-intestinal and 
orthopedic surgical procedures in 2011 were identified in the CMS database. Post-
surgical complications and financial information (in 2011 US$) were extracted from 
Medicare Standard Analytic Files and Hospital Cost Reports. Hospital margin was 
calculated as Medicare payments minus hospital costs. A total of 63 procedure codes 
(ICD-9-CM) were analyzed. RESULTS: Of 303,432 Medicare patients undergoing major 
surgery, mean costs were significantly higher for patients with at least one compli-
cation than for patients without any complication in each procedure category. For 
example, the mean cost per cardiac procedure patient with complication was $46,535, 
but only $32,887 per cardiac patient without complication. For each of the four proce-
dure categories, average hospital margins were approximately $1,500-$2,500 higher 
for patients without than with complications: $1,508 for cardiac patients, $2,336 for 
gastro-intestinal, $1,694 for orthopedic, and $2,515 for vascular patients (all p<0.0001). 
Weighted average margin were the Medicare cases with complication to be converted 
into cases without complication would be $1,870 higher per case.  For some procedure 
subgroups, the difference in average margin between cases with and without com-
plications was even higher, such as in pancreatectomy ($3,907 per case), aorto-iliac 
& peripheral bypass ($3,614), resection of rectum ($2,602), and partial hepatectomy 
procedures ($2,303) (all p<0.0001). CONCLUSIONS: Postsurgical complications have a 
significant impact on hospital margins. Enhanced Recovery Programs have potential 
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